F2 and cancer: However, it is important to recognise that minidose warfarin (1 mg day−1) can have a significant effect on the prothrombin time in cancer patients (Heaton et al, 2002; Masci et al, 2003; Mismetti et al, 2003; Magagnoli et al, 2005).